These findings are highly significant, as they suggest a broader applicability of allo-HSCT to a greater number of HIV-infected patients with cancer, including lymphoma, potentially improving their clinical outcomes.
← all excerpts
Lymphoproliferations in People Living with HIV: Oncogenic Pathways, Diagnostic Challenges, and New Therapeutic Opportunities.
1
—
—